INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Jan 09, 2004 |
SVP, PreclinDevel & Biomol Sci
Trans History: 683
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 27 | $15.60 | 17,334 |
| Jan 09, 2004 |
SVP, PreclinDevel & Biomol Sci
Trans History: 683
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 80 | $15.57 | 17,254 |
| Jan 09, 2004 |
SVP, PreclinDevel & Biomol Sci
Trans History: 683
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 27 | $15.53 | 17,227 |
| Jan 09, 2004 |
SVP, PreclinDevel & Biomol Sci
Trans History: 683
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 27 | $15.48 | 17,200 |
| Jan 09, 2004 |
SVP, PreclinDevel & Biomol Sci
Trans History: 683
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 27 | $15.47 | 17,173 |
| Jan 09, 2004 |
SVP, PreclinDevel & Biomol Sci
Trans History: 683
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 80 | $15.35 | 17,093 |
| Jan 09, 2004 |
SVP, PreclinDevel & Biomol Sci
Trans History: 683
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 27 | $15.34 | 17,066 |
| Jan 09, 2004 |
SVP, PreclinDevel & Biomol Sci
Trans History: 683
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 80 | $15.33 | 16,986 |
| Jan 09, 2004 |
SVP, PreclinDevel & Biomol Sci
Trans History: 683
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 775 | $15.32 | 16,211 |
| Jan 09, 2004 |
SVP, PreclinDevel & Biomol Sci
Trans History: 683
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 485 | $15.30 | 15,726 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.